These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 15131592

  • 1. Mutational analysis of P-glycoprotein: suppression of caspase activation in the absence of ATP-dependent drug efflux.
    Tainton KM, Smyth MJ, Jackson JT, Tanner JE, Cerruti L, Jane SM, Darcy PK, Johnstone RW.
    Cell Death Differ; 2004 Sep; 11(9):1028-37. PubMed ID: 15131592
    [Abstract] [Full Text] [Related]

  • 2. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
    Park SJ, Wu CH, Choi MR, Najafi F, Emami A, Safa AR.
    Biochem Pharmacol; 2006 Jul 28; 72(3):293-307. PubMed ID: 16753135
    [Abstract] [Full Text] [Related]

  • 3. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR.
    Tang XQ, Bi H, Feng JQ, Cao JG.
    Acta Pharmacol Sin; 2005 Aug 28; 26(8):1009-16. PubMed ID: 16038636
    [Abstract] [Full Text] [Related]

  • 4. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH.
    Life Sci; 2008 Nov 21; 83(21-22):700-8. PubMed ID: 18845169
    [Abstract] [Full Text] [Related]

  • 5. P-glycoprotein expression does not change the apoptotic pathway induced by curcumin in HL-60 cells.
    Bielak-Mijewska A, Piwocka K, Magalska A, Sikora E.
    Cancer Chemother Pharmacol; 2004 Feb 21; 53(2):179-85. PubMed ID: 14530869
    [Abstract] [Full Text] [Related]

  • 6. Anti-CD19 antibodies inhibit the function of the P-gp pump in multidrug-resistant B lymphoma cells.
    Ghetie MA, Ghetie V, Vitetta ES.
    Clin Cancer Res; 1999 Dec 21; 5(12):3920-7. PubMed ID: 10632321
    [Abstract] [Full Text] [Related]

  • 7. P-glycoprotein inhibits caspase-8 activation but not formation of the death inducing signal complex (disc) following Fas ligation.
    Ruefli AA, Tainton KM, Darcy PK, Smyth MJ, Johnstone RW.
    Cell Death Differ; 2002 Nov 21; 9(11):1266-72. PubMed ID: 12404126
    [Abstract] [Full Text] [Related]

  • 8. Suberoylanilide hydroxamic acid (SAHA) overcomes multidrug resistance and induces cell death in P-glycoprotein-expressing cells.
    Ruefli AA, Bernhard D, Tainton KM, Kofler R, Smyth MJ, Johnstone RW.
    Int J Cancer; 2002 May 10; 99(2):292-8. PubMed ID: 11979447
    [Abstract] [Full Text] [Related]

  • 9. Control of P-glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells.
    Gayet L, Dayan G, Barakat S, Labialle S, Michaud M, Cogne S, Mazane A, Coleman AW, Rigal D, Baggetto LG.
    Biochemistry; 2005 Mar 22; 44(11):4499-509. PubMed ID: 15766280
    [Abstract] [Full Text] [Related]

  • 10. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
    Sulová Z, Macejová D, Seres M, Sedlák J, Brtko J, Breier A.
    Toxicol In Vitro; 2008 Feb 22; 22(1):96-105. PubMed ID: 17920233
    [Abstract] [Full Text] [Related]

  • 11. Equivalent death of P-glycoprotein expressing and nonexpressing cells induced by the protein kinase C inhibitor staurosporine.
    Tainton KM, Ruefli AA, Smyth MJ, Johnstone RW.
    Biochem Biophys Res Commun; 2000 Sep 16; 276(1):231-7. PubMed ID: 11006111
    [Abstract] [Full Text] [Related]

  • 12. The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism.
    Chiarini F, Del Sole M, Mongiorgi S, Gaboardi GC, Cappellini A, Mantovani I, Follo MY, McCubrey JA, Martelli AM.
    Leukemia; 2008 Jun 16; 22(6):1106-16. PubMed ID: 18385752
    [Abstract] [Full Text] [Related]

  • 13. Interaction of multidrug resistance reversal agents with P-glycoprotein ATPase activity on blood-brain barrier.
    He L, Liu GQ.
    Acta Pharmacol Sin; 2002 May 16; 23(5):423-9. PubMed ID: 11978192
    [Abstract] [Full Text] [Related]

  • 14. Increased malignant behavior in neuroblastoma cells with acquired multi-drug resistance does not depend on P-gp expression.
    Kotchetkov R, Driever PH, Cinatl J, Michaelis M, Karaskova J, Blaheta R, Squire JA, Von Deimling A, Moog J, Cinatl J.
    Int J Oncol; 2005 Oct 16; 27(4):1029-37. PubMed ID: 16142320
    [Abstract] [Full Text] [Related]

  • 15. Levistolide A overcomes P-glycoprotein-mediated drug resistance in human breast carcinoma cells.
    Chen F, Wang T, Wang J, Wang ZQ, Qian M.
    Acta Pharmacol Sin; 2008 Apr 16; 29(4):458-64. PubMed ID: 18358092
    [Abstract] [Full Text] [Related]

  • 16. Effect of Stemona curtisii root extract on P-glycoprotein and MRP-1 function in multidrug-resistant cancer cells.
    Limtrakul P, Siwanon S, Yodkeeree S, Duangrat C.
    Phytomedicine; 2007 Jun 16; 14(6):381-9. PubMed ID: 17467965
    [Abstract] [Full Text] [Related]

  • 17. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD, Wu JJ, Gillespie S, Borrow J, Hersey P.
    Clin Cancer Res; 2006 Feb 15; 12(4):1355-64. PubMed ID: 16489094
    [Abstract] [Full Text] [Related]

  • 18. P-glycoprotein depresses cisplatin sensitivity in L1210 cells by inhibiting cisplatin-induced caspase-3 activation.
    Gibalová L, Sereš M, Rusnák A, Ditte P, Labudová M, Uhrík B, Pastorek J, Sedlák J, Breier A, Sulová Z.
    Toxicol In Vitro; 2012 Apr 15; 26(3):435-44. PubMed ID: 22269388
    [Abstract] [Full Text] [Related]

  • 19. Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux.
    Chavanpatil MD, Patil Y, Panyam J.
    Int J Pharm; 2006 Aug 31; 320(1-2):150-6. PubMed ID: 16713148
    [Abstract] [Full Text] [Related]

  • 20. Imatinib resistance in multidrug-resistant K562 human leukemic cells.
    Assef Y, Rubio F, Coló G, del Mónaco S, Costas MA, Kotsias BA.
    Leuk Res; 2009 May 31; 33(5):710-6. PubMed ID: 18977528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.